{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:11:07Z","timestamp":1760015467337},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ogc.2006.05.006","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:08:25Z","timestamp":1168423705000},"page":"375-388","source":"Crossref","is-referenced-by-count":8,"title":["Acquired Thrombophilia during Pregnancy"],"prefix":"10.1016","volume":"33","author":[{"given":"Francesco","family":"Dentali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2006.05.006_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1656297","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.ogc.2006.05.006_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/208143a0","article-title":"A new inherited coagulation disorder caused by an abnormal\u00a0fibrinogen (\u2018fibrinogen Baltimore\u2019)","volume":"208","author":"Beck","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.ogc.2006.05.006_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ogc.2006.05.006_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1521-6934(03)00009-9","article-title":"Homocysteine and pregnancy","volume":"17","author":"Hague","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib6","series-title":"Hemostasis and thrombosis: basic principle and clinical practice","first-page":"1085","article-title":"Approach to the thrombophilic patient","author":"Middeldorp","year":"2002"},{"key":"10.1016\/j.ogc.2006.05.006_bib7","first-page":"288","article-title":"Circulating anticoagulant as a cause of hemorrhagic diathesis in man","volume":"83","author":"Conley","year":"1948","journal-title":"Bull Hopkins Hosp"},{"key":"10.1016\/j.ogc.2006.05.006_bib8","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/ard.47.5.364","article-title":"Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients","volume":"47","author":"Derksen","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ogc.2006.05.006_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus","volume":"2","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ogc.2006.05.006_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic\u00a0stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1975.tb04897.x","article-title":"Intrauterine death and circulating anticoagulant (\u201cantithromboplastin\u201d)","volume":"197","author":"Nilsson","year":"1975","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ogc.2006.05.006_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(80)90361-X","article-title":"Possible relationship between lupus inhibitor and recurrent\u00a0abortion in young women","volume":"2","author":"Firkin","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(81)92087-0","article-title":"Arterial thrombosis, intrauterine death and \u201clupus\u201d anticoagulant: detection of immunoglobulin interfering with prostacyclin formation","volume":"1","author":"Carreras","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2006.05.006_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following\u00a0anticoagulant therapy. Duration of Anticoagulation Study Group","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.ogc.2006.05.006_bib19","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ogc.2006.05.006_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for\u00a0the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)","volume":"3","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","article-title":"Antiphospholipid antibodies and fetal death","volume":"87","author":"Oshiro","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid-antibody syndrome:\u00a0a possible thrombogenic mechanism","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I","volume":"43","author":"di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2006.05.006_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0889-857X(05)70226-X","article-title":"Management of pregnancy in antiphospholipid syndrome","volume":"27","author":"Shehata","year":"2001","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.ogc.2006.05.006_bib30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0002-9378(97)70409-5","article-title":"Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing group of the antiphospholipid antibody treatment trial","volume":"176","author":"Cowchock","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomised controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2006.05.006_bib33","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174(5)","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.006_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib35","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0306-5456(01)00272-8","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2006.05.006_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2006.05.006_bib37","first-page":"69","article-title":"Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs","volume":"30","author":"Walenga","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000073848","article-title":"Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism","volume":"33","author":"Wawrzynska","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ogc.2006.05.006_bib39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib41","series-title":"Chemically induced birth defects","first-page":"106","article-title":"Drug affecting blood","author":"Schardein","year":"1993"},{"key":"10.1016\/j.ogc.2006.05.006_bib42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1980.03300410037022","article-title":"Hazards of oral anticoagulants during pregnancy","volume":"243","author":"Stevenson","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2006.05.006_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib44","series-title":"The metabolic and molecular bases of inherited disease","first-page":"1279","article-title":"Disorders of transsulfuration","author":"Mudd","year":"1995"},{"issue":"Suppl","key":"10.1016\/j.ogc.2006.05.006_bib45","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s11745-001-0677-9","article-title":"Hyperhomocysteinemia and thrombosis","volume":"36","author":"Cattaneo","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.ogc.2006.05.006_bib46","first-page":"51","article-title":"Plasma homocysteine in venous thromboembolism","volume":"21","author":"Brattsr\u00f6m","year":"1991","journal-title":"Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90153-F","article-title":"Elevated total plasma homocysteine, a risk factor for thrombosis: relation to coagulation and fibrinolytic parameters","volume":"70","author":"Bienvenu","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.ogc.2006.05.006_bib48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocyst (e) inemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ogc.2006.05.006_bib49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","article-title":"Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus","volume":"348","author":"Petri","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib50","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.95.7.1777","article-title":"Interrelation of hyperhomocyst (e) inemia, factor V Leiden, and risk of future venous thromboembolism","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.ogc.2006.05.006_bib51","first-page":"S21","article-title":"Fasting plasma homocysteine levels do not predict the occurrence of deep-vein thrombosis after elective hip replacement surgery","volume":"52","author":"Cattaneo","year":"1998","journal-title":"Neth J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib52","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"Hyperhomocysteinemia and venous thrombosis: a meta-analysis","volume":"80","author":"den Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a metaanalysis of published epidemiological studies","volume":"3","author":"den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib54","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib55","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2006.05.006_bib56","first-page":"377","article-title":"Decreased serum homocysteine in pregnancy","volume":"30","author":"Andersson","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.ogc.2006.05.006_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0002-9378(98)80005-7","article-title":"The relationship between maternal and neonatal umbilical cord plasma homocyst (e) ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism","volume":"178","author":"Malinow","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJM199101173240315","article-title":"Neural-tube defects and derangement of homocysteine metabolism","volume":"324","author":"Steegers-Theunissen","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(95)90165-5","article-title":"Homocysteine metabolism in pregnancies complicated by neural-tube defects","volume":"345","author":"Mills","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","article-title":"Underlying disorders associated with severe early-onset preeclampsia","volume":"173","author":"Dekker","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0029-7844(99)00304-X","article-title":"Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum","volume":"94","author":"Rajkovic","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib62","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9378(98)70033-X","article-title":"Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation","volume":"179","author":"Powers","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0301-2115(96)02383-4","article-title":"Hyperhomocysteinemia: a risk factor for placental abruption or infarction","volume":"66","author":"Goddijn-Wessel","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ogc.2006.05.006_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1005373810756","article-title":"Hyperhomocysteinemia: a risk factor for abruptio placentae","volume":"20","author":"Owen","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ogc.2006.05.006_bib65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1471-0528.2000.tb13341.x","article-title":"Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy","volume":"107","author":"van der Molen","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2006.05.006_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/plac.1999.0417","article-title":"Folic acid and homocyst (e) ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review","volume":"20","author":"Ray","year":"1999","journal-title":"Placenta"},{"key":"10.1016\/j.ogc.2006.05.006_bib67","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0015-0282(16)56282-7","article-title":"Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss","volume":"60","author":"Wouters","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2006.05.006_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/humrep\/14.1.211","article-title":"Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion","volume":"14","author":"Coumans","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2006.05.006_bib69","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0015-0282(00)01595-8","article-title":"Hyperhomocysteinemia and recurrent early pregnancy loss: a metaanalysis","volume":"74","author":"Nelen","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2006.05.006_bib70","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.006_bib71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials","volume":"316","author":"Homocysteine Lowering Trialists Collaboration","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2006.05.006_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the medical research council vitamin\u00a0study. MRC vitamin study research group","volume":"338","author":"Anonymous","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2006.05.006_bib73","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2006.05.006_bib75","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.006_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(98)70263-7","article-title":"Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction","volume":"179","author":"Leeda","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2006.05.006_bib77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854506000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854506000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T13:22:02Z","timestamp":1556025722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854506000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889854506000507"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2006.05.006","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}